Literature DB >> 22470223

Propofol extravasation and tissue necrosis.

Prasanta Basak, Jennifer Poste, Stephen Jesmajian.   

Abstract

Entities:  

Year:  2012        PMID: 22470223      PMCID: PMC3312671          DOI: 10.4103/0019-5154.92692

Source DB:  PubMed          Journal:  Indian J Dermatol        ISSN: 0019-5154            Impact factor:   1.494


× No keyword cloud information.
Sir, Propofol injectable emulsion is an intravenous sedative-hypnotic agent for use in the induction and maintenance of anesthesia or sedation. Propofol is one of the most commonly used IV anesthetics.[1] It has many advantages such as a rapid onset of action, rapid recovery after long periods of anesthesia, and minimal occurrence of post procedural vomiting. Extravasation is an unintentional injection or leakage of fluid in the perivascular or subcutaneous space. Extravasation injury results from a combination of factors, including solution cytotoxicity, osmolality, vasoconstrictor properties, infusion pressure, regional anatomical peculiarities, and other patient factors.[2] Propofol extravasation does not usually lead to tissue necrosis due to the favorable chemical properties, including a neutral pH and isotonicity.[1] We report a patient who had propofol-induced necrosis of the skin. A 27-year-old female was treated for status asthmaticus. She was intubated and mechanically ventilated. Propofol was infused through an IV cannula in the left antecubital fossa. No other medications were delivered through that IV access. The bronchoconstriction got better, propofol drip discontinued, and she was successfully extubated the following day. She then reported a progressive intense burning pain in her left upper extremity. The left upper extremity was red, swollen, and warm, extending from the wrist up to the left axilla. The whole arm was extremely tender to palpation. Sensations were intact and strong radial pulses were palpated. A blister was noted on the left cubital fossa at the site of insertion of the cannula. The left arm was elevated and morphine given for pain. A Doppler ultrasound of the left upper extremity excluded venous thrombosis. The next day, the blister ruptured, exposing the underlying necrotic tissue. The arm was kept elevated, the wound dressed, and a sequential compression device applied to the left arm as recommended by the surgical consult team. Healthy granulation tissue appeared in a week [Figure 1], and the patient fully recovered without any residual sign of tissue damage.
Figure 1

Healthy granulation tissue at the site of propofol extravasation

Healthy granulation tissue at the site of propofol extravasation The induction of pain caused by propofol extravasation is probably due to activation of the kallikrein-kinin system.[3] The lipid solvent in the formulation activates the kallikrein-kinin system, and the bradykinins increase the permeability and dilatation of the veins. This increases the contact between propofol and free nerve endings in the skin, resulting in intense pain.[3] It is recommended to stop propofol infusion immediately when extravasation is suspected. A plastic surgery consult can be considered as a graft may be necessary if widespread tissue necrosis occurs. Our case had minimal tissue necrosis which resolved with supportive therapy. Although clinical reports and animal studies have shown propofol extravasation does not cause serious clinical consequences,[4-6] isolated case reports have documented extensive tissue necrosis after use of propofol.[7] ,[8] Till date, six case reports of propofol-induced tissue necrosis have been reported in adults, and one in a newborn. A wound at the site of infusion should arouse suspicion of extravasation injury. Our case highlights the need to closely monitor the propofol infusion site for any sign of inflammation, and the need for an expedited surgical consult if extravasation does occur.
  6 in total

1.  Tissue necrosis caused by extravasated propofol.

Authors:  Joho Tokumine; Kazuhiro Sugahara; Takehiko Tomori; Yoshitaka Nagasawa; Yutaka Takaesu; Akira Hokama
Journal:  J Anesth       Date:  2002       Impact factor: 2.078

2.  Extravasation injury caused by propofol.

Authors:  Rajesh Mahajan; Rahul Gupta; Anju Sharma
Journal:  Anesth Analg       Date:  2006-02       Impact factor: 5.108

3.  Extravasation injury in the perioperative setting.

Authors:  Wolfram Schummer; Claudia Schummer; Ole Bayer; Andreas Müller; Don Bredle; Waheedullah Karzai
Journal:  Anesth Analg       Date:  2005-03       Impact factor: 5.108

4.  Extravasation of propofol is associated with tissue necrosis in small children.

Authors:  Winfried Roth; Stephan Eschertzhuber; Alexander Gardetto; Christian Keller
Journal:  Paediatr Anaesth       Date:  2006-08       Impact factor: 2.556

5.  A review of the safety and tolerance of propofol ('Diprivan').

Authors:  R D Stark; S M Binks; V N Dutka; K M O'Connor; M J Arnstein; J B Glen
Journal:  Postgrad Med J       Date:  1985       Impact factor: 2.401

6.  Propofol extravasation in a breast cancer patient.

Authors:  E J M Huijbers; J W Baars; P F E Schutte; J H M Schellens; J H Beijnen
Journal:  J Oncol Pharm Pract       Date:  2008-08-27       Impact factor: 1.809

  6 in total
  2 in total

1.  Propofol extravasation: a rare cause of compartment syndrome.

Authors:  Ashish Jain Kalraiya; Suroosh Madanipour; Henry Colaco; Carlos Cobiella
Journal:  BMJ Case Rep       Date:  2015-05-07

2.  Injury due to extravasation of thiopental and propofol: Risks/effects of local cooling/warming in rats.

Authors:  Yuuka Shibata; Tomoharu Yokooji; Ryo Itamura; Yumeka Sagara; Takanori Taogoshi; Katsunari Ogawa; Maiko Tanaka; Michihiro Hide; Kenji Kihira; Hiroaki Matsuo
Journal:  Biochem Biophys Rep       Date:  2016-09-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.